NPPB and atrial fibrillation: Even in patents with a low CHADS2 score of 0 or 1, approximately 10% of the patients have TEE signs of high cardiogenic stroke risk, which may be predicted by dilatation of the LA in TTE, serum BNP level, enhanced cardiac CT, and type of AF.